SEC Form 4Coverage since Mar 24, 2026
$TPST insider trading
Over the last 12 months, Tempest Therapeutics insiders reported 1 buy totaling $500K and no sales across SEC Form 4 filings.
- Bought · 12m
- $500K 1 event
- Sold · 12m
- — 0 events
- Events · 12m
- 1 Form 4 filings, grouped
- Insiders · 12m
- 1 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $TPST · 12Mvia TradingView
Top insiders · 12m
Angel MatthewCEO and President1× · $500K
All insider trades
1 event
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | Angel MatthewCEO and President · O·D·10% | ▲ Buy | 231,482 | $2.16 | $500K | — | late · indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $TPST feed.